SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
256.40    0.60 (0.23%)
Bid:
256.40
Ask:
256.80
Spread: 0.40 (0.156%)
Market Cap: £2.52b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Director/PDMR Shareholding

23 Jun 2020 15:15

RNS Number : 8341Q
Serco Group PLC
23 June 2020
 

23 June 2020

Serco Group plc (the 'Company')

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMRs') IN ORDINARY SHARES OF 2p EACH IN THE COMPANY ('Ordinary Shares')

 

On 19 June 2020, Kevin Craven exercised nominal-cost options granted under the 2009 Serco Performance Share Plan and, on the same date, sold the full balance of Ordinary Shares acquired.

 

A summary of the Ordinary Shares acquired and sold is set out below.

 

Name of PDMR

Grant date of award

Vest date of award

Number of Ordinary Shares acquired

Ordinary Shares sold

Kevin Craven, CEO, UK & Europe

6 April 2017

6 April 2020

220,000

220,000

 

The price for the disposal of the Ordinary Shares was £1.5425 per Share.

 

This announcement is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation 596/2014.

 

The notification of dealing forms for these transactions can be found below.

 

Transaction notification

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Kevin Craven

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO, UK & Europe

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Serco Group plc ('the Company')

b)

 

LEI

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The exercise of nominal-cost options over Ordinary Shares granted on 6 April 2017 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.02

220,000

d)

 

Aggregated information

- Aggregated volume

220,000

- Price

£4,400

e)

 

Date of the transaction

 

19 June 2020

f)

 

Place of the transaction

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The sale of Ordinary Shares following the exercise of nominal-cost options over Ordinary Shares on 19 June 2020 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£1.5425

220,000

d)

 

Aggregated information

- Aggregated volume

220,000

- Price

£339,350

e)

 

Date of the transaction

 

19 June 2020

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUOASRROUNUAR
Date   Source Headline
19th Jan 20217:00 amRNSTransaction in Own Shares
18th Jan 20217:00 amRNSTransaction in Own Shares
15th Jan 20217:00 amRNSTransaction in Own Shares
14th Jan 20217:00 amRNSTransaction in Own Shares
13th Jan 20217:00 amRNSTransaction in Own Shares
12th Jan 202112:00 pmRNSDirectorate Change
12th Jan 20217:00 amRNSTransaction in Own Shares
11th Jan 20217:00 amRNSTransaction in Own Shares
8th Jan 20213:23 pmRNSHolding(s) in Company
8th Jan 20217:00 amRNSTransaction in Own Shares
7th Jan 20217:00 amRNSTransaction in Own Shares
6th Jan 20217:00 amRNSTransaction in Own Shares
5th Jan 20214:44 pmRNSHolding(s) in Company
5th Jan 20217:00 amRNSTransaction in Own Shares
4th Jan 20216:13 pmRNSHolding(s) in Company
4th Jan 202110:00 amRNSTotal Voting Rights
31st Dec 20201:00 pmRNSSerco share repurchase programme
30th Dec 20201:32 pmRNSHolding(s) in Company
24th Dec 202012:50 pmRNSHolding(s) in Company
24th Dec 202012:11 pmRNSDirector/PDMR Shareholding
21st Dec 20203:51 pmRNSHolding(s) in Company
17th Dec 20207:00 amRNSContract rebid win at Acacia Prison
17th Dec 20207:00 amRNSAustralian facilities management company acquired
17th Dec 20207:00 amRNSAngus Cockburn to retire as Serco CFO
17th Dec 20207:00 amRNSClosed period trading update
8th Dec 20204:03 pmRNSHolding(s) in Company
2nd Dec 202011:20 amRNSHolding(s) in Company
1st Dec 202011:22 amRNSTotal Voting Rights
24th Nov 20202:10 pmRNSHolding(s) in Company
13th Nov 202011:58 amRNSHolding(s) in Company
10th Nov 20209:10 amRNSHolding(s) in Company
9th Nov 20204:22 pmRNSHolding(s) in Company
9th Nov 20204:21 pmRNSHolding(s) in Company
2nd Nov 202010:11 amRNSTotal Voting Rights
2nd Nov 20207:00 amRNSAWE to transfer under direct management of MoD
16th Oct 20207:00 amRNSUnscheduled Q3 Trading Statement
9th Oct 20204:23 pmRNSDirector/PDMR Shareholding
9th Oct 20204:20 pmRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSUS Private Placement debt issuance
1st Oct 20209:46 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSChair Succession
21st Sep 20201:44 pmRNSHolding(s) in Company
1st Sep 20209:56 amRNSTotal Voting Rights
27th Aug 20203:30 pmRNSDirector/PDMR Shareholding
17th Aug 20202:45 pmRNSDirector/PDMR Shareholding
14th Aug 202011:53 amRNSHolding(s) in Company
10th Aug 202010:01 amRNSHolding(s) in Company
6th Aug 20207:00 amRNSHalf-year Report
5th Aug 202010:45 amRNSHolding(s) in Company
3rd Aug 202010:57 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.